Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to requiring the establishment of policy frameworks for research security at public institutions of higher education.
Relating to diversity, equity, and inclusion initiatives at public institutions of higher education.
Relating to the prohibition of diversity, equity, and inclusion offices and employees at public institutions of higher education.
Relating to prohibiting public institutions of higher education from requiring diversity training as a condition for enrollment or registration.
Relating to prohibiting public institutions of higher education from requiring diversity training as a condition for enrollment or registration.
Relating to the accreditation of public institutions of higher education; providing a private cause of action.
Relating to insurance coverage for the disposition of embryonic and fetal tissue remains.
Relating to prohibiting a public institution of higher education from partnering with certain private entities for the construction of a student housing facility.
Relating to prohibiting certain academic boycotts of foreign countries by public institutions of higher education.